ASFaVIP FINAL STAKEHOLDER MEETING
ASF: An Analysis of Current Situation of Vaccine Development; Licensing Procedures and Possible Eradication Approaches Frankfurt - Germany December 3, 2026
ASFaVIP has received funding from the European Union’s Horizon Europe research and innovation program under grant agreement No 101136676. It was funded within work program topic HORIZON-CL6-2023-FARM2FORK-01-5.
